ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MLS Medical Solutn

7.72
0.00 (0.00%)
17 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medical Solutn LSE:MLS London Ordinary Share GB0009739649 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 7.72 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Source BioScience PLC Holding(s) in Company (4784F)

12/11/2015 10:18am

UK Regulatory


TIDMSBS

RNS Number : 4784F

Source BioScience PLC

12 November 2015

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 
 
 
 1. Identity of the issuer      SOURCE BIOSCIENCE PLC 
  or the underlying issuer 
  of existing shares to which 
  voting rights are attached: 
  (ii) 
-----------------------------  ---------------------- 
 
 
 2 Reason for the notification (please tick the 
  appropriate box or boxes): 
---------------------------------------------------- 
 An acquisition or disposal of voting rights     YES 
----------------------------------------------  ---- 
 An acquisition or disposal of qualifying 
  financial instruments which may result in 
  the acquisition of shares already issued 
  to which voting rights are attached 
----------------------------------------------  ---- 
 An acquisition or disposal of instruments 
  with similar economic effect to qualifying 
  financial instruments 
----------------------------------------------  ---- 
 An event changing the breakdown of voting 
  rights 
----------------------------------------------  ---- 
 Other (please 
  specify): 
--------------------------------------------    ---- 
 
 
 
 3. Full name of person(s) 
  subject to the notification               Harwood Capital LLP 
  obligation: (iii)                   (as investment adviser/manager) 
                                            and North Atlantic 
                                       Smaller Companies Investment 
                                                 Trust plc 
---------------------------------  ---------------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):                1. NORTH ATLANTIC SMALLER 
  (iv)                                     COMPANIES INVESTMENT 
                                                 TRUST PLC 
 
                                           2. ORYX INTERNATIONAL 
                                            GROWTH FUND LIMITED 
---------------------------------  ---------------------------------- 
 5. Date of the transaction                  6 NOVEMBER 2015 
  and date on which the threshold 
  is crossed or reached: (v) 
---------------------------------  ---------------------------------- 
 6. Date on which issuer                    10 NOVEMBER 2015 
  notified: 
---------------------------------  ---------------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                       Total Holding through 
                                                    17% 
---------------------------------  ---------------------------------- 
 
 
 8. Notified details: 
----------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
----------------------------------------------------------------------------------------------------------- 
 Class/type      Situation                     Resulting situation after 
  of              previous                      the triggering transaction 
  shares          to the triggering 
                  transaction 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  ----------------------------  ------------------------------------------------------------- 
                 Number         Number         Number         Number of                 % of voting 
                  of             of             of             voting                    rights (x) 
                  Shares         Voting         shares         rights 
                                 Rights 
--------------  -------------  -------------  -------------  ------------------------  -------------------- 
                                               Direct         Direct         Indirect   Direct     Indirect 
                                                               (xi)           (xii) 
--------------  -------------  -------------  -------------  -------------  ---------  ---------  --------- 
 
   HOLDER 
   1 
                   7,650,000      7,650,000      11,500,000     11,500,000                3.29% 
   HOLDER 
   2               50,000,000     50,000,000     50,000,000     50,000,000                14.32% 
--------------  -------------  -------------  -------------  -------------  ---------  ---------  --------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------- 
 Type of financial   Expiration   Exercise/     Number of      % of voting 
  instrument          date         Conversion    voting         rights 
                      (xiii)       Period        rights that 
                                   (xiv)         may be 
                                                 acquired 
                                                 if the 
                                                 instrument 
                                                 is 
                                                 exercised/ 
                                                 converted. 
------------------  -----------  ------------  -------------  ------------ 
 
 
 
 C: Financial Instruments with similar economic 
  effect to Qualifying Financial Instruments (xv, 
  xvi) 
---------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------- 
 Type of       Exercise   Expiration   Exercise/     Number of     % of voting 
  financial     price      date         Conversion    voting        rights (xix, 
  instrument               (xvii)       period        rights        xx) 
                                        (xviii)       instrument 
                                                      refers 
                                                      to 
------------  ---------  -----------  ------------  ------------  ---------------- 
                                                                   Nominal   Delta 
------------  ---------  -----------  ------------  ------------  --------  ------ 
 
 
 
 Total (A+B+C) 
----------------------------------------------- 
 Number of voting rights   Percentage of voting 
                            rights 
------------------------  --------------------- 
 61,500,000                  17.61% 
------------------------  --------------------- 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
------------------------------------------------------------ 
 
 
 
 Proxy Voting: 
-------------------------------- 
 10. Name of the proxy holder: 
------------------------------ 
 11. Number of voting rights 
  proxy holder will cease 
  to hold: 
------------------------------ 
 12. Date on which proxy 
  holder will cease to hold 
  voting rights: 
------------------------------ 
 
 
 13. Additional information: 
-------------------------------  -------------- 
 14. Contact name:                Jane Muir 
-------------------------------  -------------- 
 15. Contact telephone number:    020 8819 6486 
-------------------------------  -------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLGGGQGGUPAGUP

(END) Dow Jones Newswires

November 12, 2015 05:18 ET (10:18 GMT)

1 Year Medical Solutions Chart

1 Year Medical Solutions Chart

1 Month Medical Solutions Chart

1 Month Medical Solutions Chart

Your Recent History

Delayed Upgrade Clock